421 related articles for article (PubMed ID: 25070750)
1. How we approach an acquired thrombotic thrombocytopenic purpura patient.
Raval JS; Mazepa MA; Brecher ME; Park YA
Transfusion; 2014 Oct; 54(10):2375-82. PubMed ID: 25070750
[TBL] [Abstract][Full Text] [Related]
2. Current management and therapeutical perspectives in thrombotic thrombocytopenic purpura.
Coppo P; Veyradier A
Presse Med; 2012 Mar; 41(3 Pt 2):e163-76. PubMed ID: 22265954
[TBL] [Abstract][Full Text] [Related]
3. Atypical presentations of thrombotic thrombocytopenic purpura: a review.
Sarode R
J Clin Apher; 2009; 24(1):47-52. PubMed ID: 19073011
[TBL] [Abstract][Full Text] [Related]
4. Management of Thrombotic Microangiopathic Hemolytic Anemias with Therapeutic Plasma Exchange: When It Works and When It Does Not.
Mehmood T; Taylor M; Winters JL
Hematol Oncol Clin North Am; 2016 Jun; 30(3):679-94. PubMed ID: 27113004
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura: a retrospective multicenter study.
Korkmaz S; Keklik M; Sivgin S; Yildirim R; Tombak A; Kaya ME; Acik DY; Esen R; Hacioglu SK; Sencan M; Kiki I; Tiftik EN; Kuku I; Okan V; Yilmaz M; Demir C; Sari I; Altuntas F; Unal A; Ilhan O
Transfus Apher Sci; 2013 Jun; 48(3):353-8. PubMed ID: 23602056
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in thrombotic thrombocytopenic purpura.
Sadler JE; Moake JL; Miyata T; George JN
Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
[TBL] [Abstract][Full Text] [Related]
7. Rapid ADAMTS13 availability impacts treatment for microangiopathic hemolytic anemia and thrombocytopenia.
Martin IW; Katus MC; Martin CL; Szczepiorkowski ZM; Gorham JD; Dunbar NM
J Clin Apher; 2016 Oct; 31(5):419-22. PubMed ID: 26332753
[TBL] [Abstract][Full Text] [Related]
8. Thrombotic thrombocytopenic purpura in childhood: an uncommon but life-threatening cause of thrombocytopenia.
Davis A; Barnes C
J Paediatr Child Health; 2007 Sep; 43(9):640-2. PubMed ID: 17688649
[TBL] [Abstract][Full Text] [Related]
9. Successful management of thrombotic thrombocytopenic purpura in a Jehovah's Witness without plasma exchange.
Chai W; Chaudhry A; Rabinowitz AP
J Clin Apher; 2015 Feb; 30(1):46-9. PubMed ID: 24782109
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic plasma exchange for thrombotic thrombocytopenic purpura with refractory thrombocytopenia.
Maloney N; Martin I; Szczepiorkowski ZM; Dunbar NM
J Clin Apher; 2018 Jun; 33(3):436-438. PubMed ID: 29270999
[TBL] [Abstract][Full Text] [Related]
11. Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP).
Shah N; Rutherford C; Matevosyan K; Shen YM; Sarode R
Br J Haematol; 2013 Nov; 163(4):514-9. PubMed ID: 24111495
[TBL] [Abstract][Full Text] [Related]
12. Performance of a clinical prediction score for thrombotic thrombocytopenic purpura in an independent cohort.
Bentley MJ; Wilson AR; Rodgers GM
Vox Sang; 2013 Nov; 105(4):313-8. PubMed ID: 23662653
[TBL] [Abstract][Full Text] [Related]
13. Intravenous immunoglobulin as an adjunct to plasma exchange for the treatment of chronic thrombotic thrombocytopenic purpura.
Moore JC; Arnold DM; Leber BF; Clare R; Molnar GJ; Kelton JG
Vox Sang; 2007 Aug; 93(2):173-5. PubMed ID: 17683362
[TBL] [Abstract][Full Text] [Related]
14. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome in children and adolescents.
Lowe EJ; Werner EJ
Semin Thromb Hemost; 2005 Dec; 31(6):717-30. PubMed ID: 16388423
[TBL] [Abstract][Full Text] [Related]
15. Rituximab and intermediate-purity plasma-derived factor VIII concentrate (Koate®) as adjuncts to therapeutic plasma exchange for thrombotic thrombocytopenic purpura in patients with an ADAMTS13 inhibitor.
Pandey S; Nakagawa M; Rosenbaum ER; Arnaoutakis K; Hutchins LF; Makhoul I; Milojkovic N; Cottler-Fox M
J Clin Apher; 2015 Feb; 30(1):50-4. PubMed ID: 25042026
[TBL] [Abstract][Full Text] [Related]
16. Indicators Differentiating Thrombotic Thrombocytopenic Purpura From Other Thrombotic Microangiopathies in a Canadian Apheresis Referral Center.
Martin SD; McGinnis E; Smith TW
Am J Clin Pathol; 2021 Nov; 156(6):1103-1112. PubMed ID: 34160013
[TBL] [Abstract][Full Text] [Related]
17. Evaluation and management of patients with thrombotic thrombocytopenic purpura.
George JN
J Intensive Care Med; 2007; 22(2):82-91. PubMed ID: 17456728
[TBL] [Abstract][Full Text] [Related]
18. Absolute immature platelet count dynamics in diagnosing and monitoring the clinical course of thrombotic thrombocytopenic purpura.
Hong H; Xiao W; Stempak LM; Sandhaus LM; Maitta RW
Transfusion; 2015 Apr; 55(4):756-65. PubMed ID: 25370931
[TBL] [Abstract][Full Text] [Related]
19. Post-appendectomy thrombotic thrombocytopenic purpura: a case report and review of the literature.
Robertson MD; Zumberg M
Am J Hematol; 2007 Mar; 82(3):224-8. PubMed ID: 17034025
[TBL] [Abstract][Full Text] [Related]
20. Practical issues in ADAMTS13 testing and emerging therapies in thrombotic thrombocytopenic purpura.
Cataland SR; Wu HM
Semin Hematol; 2011 Oct; 48(4):242-50. PubMed ID: 22000089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
